Detalhe da pesquisa
1.
A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia.
Cancer Immunol Immunother
; 67(10): 1505-1518, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30039426
2.
The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study.
Cancer Immunol Immunother
; 62(3): 489-501, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22986454
3.
Design of neo-glycoconjugates that target the mannose receptor and enhance TLR-independent cross-presentation and Th1 polarization.
Eur J Immunol
; 41(4): 916-25, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21400496
4.
The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools.
Cancer Immunol Immunother
; 61(11): 1953-63, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22491788
5.
Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses.
Int J Cancer
; 128(6): 1371-83, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20473945
6.
S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions.
Proc Natl Acad Sci U S A
; 105(49): 19474-9, 2008 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-19047644
7.
Transfer of Cellular Content from the Allogeneic Cell-Based Cancer Vaccine DCP-001 to Host Dendritic Cells Hinges on Phosphatidylserine and Is Enhanced by CD47 Blockade.
Cells
; 10(11)2021 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34831455
8.
CIMT 2010: report on the eighth annual meeting of the Association for Cancer Immunotherapy, May 26-28, 2010, Mainz, Germany.
Cancer Immunol Immunother
; 60(3): 443-50, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21104411
9.
Characterization of murine MGL1 and MGL2 C-type lectins: distinct glycan specificities and tumor binding properties.
Mol Immunol
; 46(6): 1240-9, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19162326
10.
Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Mol Immunol
; 47(2-3): 164-74, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19818504